References
- Global I for chronic obstructive pulmonary disease. Global Strategy for Diagnosis, Management, and Prevention of COPD; 2011 Update
- Spencer S. Health status measurement in exacerbations of COPD. Expert Rev Respir Med 2009;3(6):573-83
- Global I for chronic obstructive pulmonary disease. Global Strategy for Diagnosis, Management, and Prevention of COPD; 2013 Update
- Kocks JW, van der Molen T. Risk indexes for COPD exacerbations II. Chest 2007;131(6):1986-7. author reply 1987
- Jones PW. Health status: what does it mean for payers and patients? Proc Am Thorac Soc 2006;3(3):222-6
- Antoniu SA. Effects of inhaled therapies on health-related quality of life in stable chronic obstructive pulmonary disease. Expert Rev Pharmacoecon Outcomes Res 2010;10(2):155-62
- Trappenburg J, Touwen I, de Weert-van Oene GH, et al. Detecting exacerbations using the Clinical COPD Questionnaire. Health Qual Life Outcomes 2010;8(1):102
- Ställberg B, Nokela M, Ehrs PO, et al. Validation of the clinical COPD Questionnaire (CCQ) in primary care. Health Qual Life Outcomes 2009;7:26
- Bech P, Gudex C, Johansen KS. The WHO (Ten) Well-Being Index: validation in diabetes. Psychother Psychosom 1996;65:183-90
- Lucas-Carrasco R, Allerup P, Bech P. The validity of the WHO-5 as an early screening for apathy in an elderly population. Curr Gerontol Geriatr Res 2012;2012:171857
- Witek TJ Jr, Mahler DA. Minimal important difference of the transition dyspnoea index in a multinational clinical trial. Eur Respir J 2003;21(2):267-72
- Rutten-van Mölken MP, Oostenbrink JB, Tashkin DP, et al. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Chest 2006;130(4):1117-28
- Mahler DA, Weinberg DH, Wells CK, et al. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984;85(6):751-8
- Bech P. Measuring the dimensions of psychological general well-being by the WHO-5. QoL Newsletter 2004;32:15-16
- van der Molen T, Willemse BW, Schokker S, et al. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes 2003;1:13
- Kocks JW, Tuinenga MG, Uil SM, et al. Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire. Respir Res 2006;7:62
- Miravitlles M, Izquierdo I, Herrejón A, et al. COPD severity score as a predictor of failure in exacerbations of COPD. The ESFERA study. Respir Med 2011;105(5):740-7
- Xu W, Collet JP, Shapiro S, et al. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit Care Med 2008;178(9):913-20
- Aaron SD, Vandemheen KL, Clinch JJ, et al. Measurement of short-term changes in dyspnea and disease-specific quality of life following an acute COPD exacerbation. Chest 2002;121(3):688-96
- Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992;145(6):1321-7
- Tsai CL, Hodder RV, Page JH, et al. The short-form chronic respiratory disease questionnaire was a valid, reliable, and responsive quality-of-life instrument in acute exacerbations of chronic obstructive pulmonary disease. J Clin Epidemiol 2008;61(5):489-97
- Mackay AJ, Donaldson GC, Patel AR, et al. Usefulness of the chronic obstructive pulmonary disease assessment test to evaluate severity of COPD exacerbations. Am J Respir Crit Care Med 2012;185(11):1218-24